COVID-19 resurgence: India logs 163 cases of new XFG variant; experts address danger, early symptoms and more
Apart from this, the Indian SARS-CoV-2 Genomics Consortium (INSACOG) data noted that 163 cases of the XFG variant of COVID-19 have been detected across the country, including in the states of Maharashtra, Tamil Nadu, Kerala, Gujarat, West Bengal and Andhra Pradesh.
Moreover, Maharashtra has reported the highest number of XFG cases, with 89 infections so far.
What is the XFG variant of COVID-19, and is it dangerous?
India has detected new cases of a new Omicron-derived COVID-19 variant called XFG, first identified in Canada. 'If one is infected with this variant, then he/she can exhibit symptoms such as fever, dry cough, sore throat, headache, fatigue, body pain, nasal congestion, and runny nose,' warns Dr Samir Garde, Director of the Department of Pulmonology and Lung Transplant, Gleneagles Hospital, Parel.
🔍Weekly #EventBasedSurveillance | India#India has reported 6,851 active #COVID-19 cases, as per the latest data from the Ministry of Health and Family Welfare. The rise in infections is attributed to the spread of #Omicron sub-variants, particularly the newly detected XFG… pic.twitter.com/4c6s5wko2l
'However, this variant is not known to cause any severe illness or hospitalisation or higher morbidity and mortality rates in patients,' adds Dr.Garde.
The symptoms due to this variant are reported to be mild. According to Dr. Garde, 'People need to be cautious and take utmost care of their well-being, as this XFG variant can spread rapidly. Hence, people should not panic. However, if you have any of these symptoms, then isolate yourself from your family members.
'Moreover, follow the doctor's advice after a confirmed diagnosis. Don't self-medicate at all. "To prevent the infection, get tested if you have flu-like symptoms and maintain respiratory hygiene, that is, wear a mask in crowded places and sneeze into your elbow and opt for handwashing,' he adds.
Is the month of June the peak season for COVID-19 resurgence?
Recently, the health authorities in Ludhiana flagged a concerning uptick in COVID-19 cases, with the district's positivity rate jumping to 7.14 per cent in early June, which is the highest monthly figure noted this year, reports ToI.
As per the report, the number is nearly 12 times higher than in May. Does the month of June see a COVID-19 resurgence? 'New variants like XFG are likely more transmissible due to genetic mutations. "The situation demands caution, especially in crowded areas and among vulnerable populations,' says Dr. Sheela Chakravarthy, Director of Internal Medicine, Fortis Hospital, Bannerghatta Road, Bengaluru.
Wearing masks, practising good hygiene, and staying updated with COVID-19 vaccine doses are crucial. 'Close monitoring and prompt public health action will help control the spread and mitigate the impact of this resurgence, protecting public health and preventing severe disease and hospitalisation. "Precautions are essential for all, particularly the elderly and those with comorbidities,' adds Dr. Chakravarthy.
To stay updated on the stories that are going viral, follow Indiatimes Trending.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Hindustan Times
38 minutes ago
- Hindustan Times
Ludhiana: Khanna civil hospital gynaec suspended for ‘negligence' after newborn's death
Punjab health and family welfare minister Dr Balbir Singh today ordered immediate suspension of a gynaecologist at the Khanna civil hospital for 'negligence' in connection with a newborn's death. The minister warned that the doctor's medical licence could be revoked and legal action may follow pending further investigation. Punjab health and family welfare minister Dr Balbir Singh addressing mediapersons at Khanna hospital. (HT Photo) The patient, Manpreet Kaur, a pregnant woman, was brought to the hospital around 8 pm on July 21 by her family. Despite undergoing regular treatment at the facility for nine months, she was referred to another hospital during delivery hours. The attending emergency doctor, Dr Amardeep, allegedly consulted gynecologist Dr Kavita Sharma over phone who suggested referring the patient to Patiala, instead of arriving at the hospital to assess her condition. Senior medical officer (SMO) Dr Maninder Singh Bhasin rushed to the hospital at around 10 pm, called in a pediatrician and anesthetist, and proceeded to conduct an emergency C-section himself. The surgery was successfully performed, stabilising the mother's condition. However, the newborn, who had ingested meconium in the womb, was in a critical state. Despite efforts to resuscitate the infant, she was referred first to Patiala, where a lack of ventilator facilities prompted a second referral to PGIMER in Chandigarh. The family alleged that the ambulance ferrying the newborn ran out of oxygen midway, causing further distress. 'By the time a second ambulance was arranged, her body had turned blue,' said Raj Lakhia, baby's uncle. The infant was declared dead on arrival at PGIMER. 'Any negligence in patient care is unacceptable and will face strict consequences,' said the minister. Following the incident, a three-member committee, comprising an SMO and two specialists, was constituted to investigate. The committee's report found the gynaecologist's failure to address the case with due seriousness. In a message to health staff, Dr Singh urged them to perform their duties with utmost honesty, dedication and diligence, warning of severe repercussions for lapses. He commended the health department's workforce, highlighting that 98% of its doctors risked their lives during the Covid-19 pandemic to save countless lives. 'Plans afoot to hire medics' In response to queries about the shortage of doctors in Doraha and Payal hospitals, Dr Singh noted that the state has recruited approximately 3,000 healthcare workers recently, with plans to onboard 1,000 additional doctors soon. He outlined plans to ensure 24-hour maternal and child care, emergency services and initial treatment for heart attacks and neurological conditions at district-level and highway-adjacent government hospitals. Additionally, he stated that the government would establish 10-12 advanced hospitals across Punjab for specialised treatments, including heart surgeries, organ transplants and orthopedic care. He also highlighted that government hospitals in Khanna, Tarn Taran, Dasuya, Tanda and Chamkaur Sahib were already providing initial care for heart attack patients, with referrals to larger facilities for advanced treatment. He also announced that Punjab is set to become the first state in India to offer free health insurance (worth up to ₹10 lakh) to its entire population of 3 crore. Dr Balbir Singh also conducted house-to-house inspections to check larvae in various parts of Khanna. He urged the community to prevent mosquito breeding by ensuring water does not accumulate in containers, rooftops, or courtyards. He stated that the health department is fully committed to curbing dengue's spread, emphasising that the campaign's primary goal is to protect lives from this potentially fatal disease. He called on residents to maintain cleanliness, prevent water stagnation, and ensure proper drainage in their surroundings.
Indian Express
3 hours ago
- Indian Express
Why minimum standards for handling diagnostic samples are important
The Union Ministry of Health and Family Welfare (MoHFW) last week assured the Delhi High Court that it will soon notify minimum clinical standards for collection, handling, and transport of diagnostic samples. The MoHFW said that subject experts held 'detailed internal deliberations for formulating minimum standards' following which the draft minimum standards were finalised. The policy is currently being vetted by the legislative department of the Ministry of Law & Justice, the MoHFW told the court. Existing Indian Council of Medical Research (ICMR) guidelines on collection and handling of clinical samples are rudimentary and piecemeal. For instance, the Pune-based ICMR-National Institute of Virology (NIV) has specific 'Guidelines for collection, packaging and transport of specimens for testing for high risk viral pathogens', which include guidelines for handling samples containing Covid-19 virus. These guidelines, however, are not comprehensive: they only relate to handling of specific 'high risk' viruses. These are also not uniformly enforced owing to gaps in the law governing labs and sample collection centres, as well as its enforcement. Medical professionals have long been calling for reform; the MoHFW's soon-to-be-notified policy seeks to answer this call. Beyond lack of comprehensive clinical guidelines, experts have pointed to a couple of significant loopholes vis-à-vis the medical testing ecosystem. 🔴 First is the continued existence of standalone collection centres. In 2018, the Centre had notified that sample collection centres should be part of the main laboratories, and that the parent laboratories should be held accountable for their compliance of norms. But in the absence of clear-cut standards, standalone collection centres continue to be registered in various states, posing a fundamental problem when it comes to ensuring compliance with clinical standards. In November 2020, the National Accreditation Board for Testing and Calibration Laboratories (NABL) had flagged that 'there are mismatches in the declaration (of samples) made by (accredited) lab to NABL and the actual collection centres/facilities/sources of collection which are available on their websites or other documents'. At the time, it advised labs to declare all sample collection centres within 30 days, and cautioned that 'any sample collection not under the responsibility of the lab and not covered under its (quality) management system is non-compliant with the accreditation norms and liable to action by NABL.' The MoHFW's new policy will likely address this issue. 🔴 Experts have also called for revisiting current laws guiding 'who' can collect samples and issue reports. In 2019, pathologist Dr Rohit Jain moved the Delhi High Court, challenging the Clinical Establishments (Central Government) Amendment Rules 2018, specifically on minimum requirements for signatory authorities in diagnostic laboratories. He sought implementation of a 2017 order of the Supreme Court, which said that a lab report should be counter-signed only by a registered medical practitioner with a post graduate qualification in pathology. At the time, he also sought guidelines on minimum standards for medical diagnostic labs with regard to sample collection centres, sample transport, electronic signatures on pathological reports by authorised signatories, number of pathology labs a pathologist can visit in a day and on daily internal quality control. But the Centre's Clinical Establishment (Central Government) Amendment Rules 2020 did not address the issue, allowing 'unqualified and unregistered non-medical persons viz MSc/PhD were authorised to issue pathology reports without the signature/counter signature of a pathologist,' according to Jain. Jain challenged these amended rules, and in August 2021, also moved court highlighting an RT-PCR testing 'scam' during the Kumbh Mela in Haridwar that year where one lakh fake tests were reportedly conducted on devotees by unqualified intermediaries. 'The accused diagnostic labs in Delhi and Haryana were able to collect samples and conduct a huge number of tests where they have no sample collection centres at Uttarakhand. It is clear that a scam of such enormity has only been possible because of the lack of essential minimum standards on the issue of sample collection/sample collection centres and sample transport policy,' Jain had argued in his submission. In 2023, the Delhi High Court directed the Centre to consider Jain's plea as a representation and decide a solution in three months. In May 2023, the government held a meeting under the chairmanship of the Additional Director-General of Health Services, New Delhi, where Jain too was invited to make his representation. After the meeting, the government decided to constitute four sub-committees of experts — pathology, biochemistry, hematology and microbiology — to define standards of procedure (SOPs) for sample collection, collection centres and sample transport policy. When these guidelines were not notified even a year later, Jain in May 2024 moved the Delhi High Court again, accusing the government of wilful disobedience of the court's order. It is in this matter that the MoHFW has now assured the court that a policy will be notified at the earliest. Taking the ministry's submission on record, the court instructed that the standards be notified expeditiously, with a direction that the process 'may be accomplished within the next three months'.
Time of India
6 hours ago
- Time of India
2,426 cr Covid fight bill hit state economy hard: Report
1 2 3 Visakhapatnam: The Covid-19 pandemic not only triggered a public health emergency but also imposed significant financial pressure on the Andhra Pradesh exchequer. Between 2019–20 and 2022–23, the state incurred an expenditure of 4,606 crore on various Covid-19 prevention and management measures, according to the CAG report. Andhra Pradesh was among the hardest-hit states, recording over 23 lakh cases—ranking fifth in the country in terms of case load. In response to the emerging crisis, the state ramped up healthcare infrastructure beginning February 2020. Key initiatives included setting up diagnostic labs, expanding testing capacity, procuring medicines and vaccines, strengthening oxygen supply networks, and mobilizing critical medical resources. Although public health is a state responsibility, the Union Ministry of Health and Family Welfare provided both technical and financial aid to assist states in managing the pandemic. The Centre introduced the Emergency Covid Response Package (ECRP) to curb transmission and mitigate impact. Under ECRP-I, funds released to Andhra Pradesh in FY 2020–21 were fully borne by the Centre. In 2021–22, the funding was shared between Centre and state in a 60:40 ratio. According to the CAG report, during the four-year period, Andhra Pradesh received a total allocation of 4,961.36 crore (both Central and state share) and spent 4,606 crore. Of this, the state govt on its part spent 2,426.47 crore. GoI's share amounted to 1,876.44 crore, of which 1,612.45 crore was utilised. From the state disaster response fund, 140.95 crore was used out of the allocated 187.87 crore. Meanwhile, 426.13 crore was spent from the district mineral fund, against an allocation of 534.41 crore. At the onset of the pandemic in Feb 2020, Andhra Pradesh had no Covid-19 testing infrastructure. The state responded swiftly by establishing 135 testing laboratories. Until these labs became operational, test samples had to be sent to other states for processing. During the second wave, the state expanded the number of Covid-19 treatment hospitals from 260 in the first wave to over 640. It also ramped up human resources, recruiting 17,300 doctors and support staff during the first wave, and an additional 18,000 medical personnel during the second wave. Notably, Andhra Pradesh became one of the few states in India to achieve 100% double-dose vaccination coverage among eligible population groups. In a major welfare initiative, Andhra Pradesh became the first state in the country to include Covid-19 treatment under its flagship Arogyasri health scheme (now renamed as NTR Vaidya Seva). This decision enabled over 1 lakh patients to receive free inpatient treatment at private hospitals across the state.
